TREA

Display screen with a graphical user interface

Follow

Information

  • Patent Grant
  • D1081702
  • Patent Number
    D1,081,702
  • Date Filed
    Monday, November 2, 2020
    5 years ago
  • Date Issued
    Tuesday, July 1, 2025
    6 months ago
  • US Classifications
    Field of Search
    • US
    • D14 485-495
    • CPC
    • H04L41/22
    • G16H10/20
    • G06Q10/103
    • G06Q10/063
    • G06F3/048
    • G06F3/0481
    • G06F3/04812
    • G06F3/04815
    • G06F3/04817
    • G06F3/0482
    • G06F3/0483
    • G06F3/0484
    • G06F3/04842
    • G06F3/04845
    • G06F3/04847
    • G06F3/0485
    • G06F3/04855
    • G06F3/0486
    • G06F3/0487
    • G06F3/0488
    • G06F3/04883
    • G06F3/04886
    • G06F40/103
    • G06F40/106
  • International Classifications
    • 1404
    • Term of Grant
      15Years
      Disclaimer
      This patent is subject to a terminal disclaimer.
Information
Abstract
Description

The FIGURE is a front view of a display screen with a graphical user interface.


Claims
  • The ornamental design for a display screen with a graphical user interface, as shown and described.
US Referenced Citations (72)
Number Name Date Kind
D344102 Polak Feb 1994 S
D502184 Glezer Feb 2005 S
7030890 Jouet Apr 2006 B1
D594911 Hall Jun 2009 S
7818689 Wada Oct 2010 B2
8286072 Chamberlain Oct 2012 B2
D673577 Cojuangco Jan 2013 S
D698361 Stiffler Jan 2014 S
D715834 Siddons Oct 2014 S
D723048 Helliker Feb 2015 S
D732058 Landis Jun 2015 S
D753174 Cojuangco Apr 2016 S
D759072 Siddons Jun 2016 S
D769315 Scotti Oct 2016 S
D771107 Spector Nov 2016 S
D772276 Yampolskiy Nov 2016 S
D788790 Omata Jun 2017 S
D792448 Take Jul 2017 S
D799499 Selden Oct 2017 S
D803248 Sunshine Nov 2017 S
D819687 Yampolskiy Jun 2018 S
D841030 Bradley-Pollack Feb 2019 S
D841031 Orlando Feb 2019 S
D841675 Hoffman Feb 2019 S
D854558 Melillo Jul 2019 S
D855634 Kim Aug 2019 S
D870762 Mendoza Corominas Dec 2019 S
D873846 Melillo Jan 2020 S
D877747 Belliveau Mar 2020 S
D880517 Imamura Apr 2020 S
D881927 Tsukahara Apr 2020 S
D882598 Belliveau Apr 2020 S
10613711 Makovsky Apr 2020 B1
D895642 Hoofnagle Sep 2020 S
D900840 Dudey Nov 2020 S
D916869 Evangeliou Apr 2021 S
D922422 Molander Jun 2021 S
D924906 Nie Jul 2021 S
D924909 Nasu Jul 2021 S
D928194 Baker Aug 2021 S
11132552 Naslavsky Sep 2021 B1
D937862 Anderson Dec 2021 S
D950580 Ahmed May 2022 S
D963677 Bahatyrevich Sep 2022 S
D978887 Caro Feb 2023 S
D980863 Balsamo Mar 2023 S
D985602 Walecka May 2023 S
D1040175 Potash Aug 2024 S
D1052603 Ganapathy Nov 2024 S
D1055947 Harmon Dec 2024 S
D1060404 Arora Feb 2025 S
D1061592 Khokhar Feb 2025 S
20050055241 Horstmann Mar 2005 A1
20080120574 Heredia May 2008 A1
20110153358 Campo et al. Jun 2011 A1
20130232104 Goyal et al. Sep 2013 A1
20140039921 Broverman et al. Feb 2014 A1
20150213547 Gomez-Rosado Jul 2015 A1
20170075557 Noble Mar 2017 A1
20170147794 Harder May 2017 A1
20170286456 Wenzel et al. Oct 2017 A1
20170323320 Mendoza Corominas Nov 2017 A1
20180039399 Kaltegaertner et al. Feb 2018 A1
20180261305 Lindblad Sep 2018 A1
20200335188 Ozeran Oct 2020 A1
20200394612 Khokhar Dec 2020 A1
20220004540 Watson et al. Jan 2022 A1
20220005554 Malfait et al. Jan 2022 A1
20220005555 Malfait et al. Jan 2022 A1
20220005558 Malfait et al. Jan 2022 A1
20230274809 Dimitrova Aug 2023 A1
20230360779 Gnanasambandam et al. Nov 2023 A1
Non-Patent Literature Citations (46)
Entry
Kemegne, Gislaine Aurelie et al., Comparing checkerboard, isobologram and CCD methods for drug combination, Oct. 31, 2021, AcademicJournals.org, retrieved Oct. 24, 2023, https://academicjournals.org/journal/JMPR/article-full-text/C8764D068023 (Year: 2021).
Dandapandi, Hari G., Leveraging Mobile-Based Sensors for Clinical Research, Jun. 13, 2022, FrontiersIn.org, retrieved Feb. 28, 2025, https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2022.893070/full (Year: 2022).
Kriebel, Andy, How to Create a Dot Strip Plot, Jun. 8, 2021, YouTube.com, retrieved Feb. 28, 2025, https://www.youtube.com/watch?v=fKSL-IMqILA (Year: 2021).
“Clinical trials and their patients: The rising costs and how to stem the loss,” Pharmafile, accessed from http:/www.pharmafile.com/print/511225, Mar. 11, 2016, 6 pp.
“ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials,” European Medicines Agency, Committee for Medicinal Products for Human Use, EMA/CHMP/CH/4362221/2017, Feb. 17, 2020, 19 pp.
“Nurocor Clinical Platform—Technical Perspective,” Nurocor, Inc., accessed on Apr. 29, 2020, 11 pp.
“Optimize Clinical Development,” Nurocor and Intilaris brochure, accessed on Sep. 9, 2020, 2 pp.
Nelson et al., “CDISC 2019 US Interchange,” [Presentation], CDISC, San Diego, CA, Oct. 14-18, 2019, 19 pp.
Kountouris et al., “Efficient scheduling of conditional behaviors for high-level synthesis,” ACM Transactions on Design Automation of Electronic Systems, vol. 7, No. 3, Jul. 1, 2002, pp. 380-412.
Lin et al., “A Standard-Driven Approach for Electric Submission to Pharmaceutical Regulatory Authorities”, Journal of Biomedical Informatics, vol. 79, Jan. 31, 2018, pp. 60-70.
“Executive Summary—Digital Data Flow Solution Framework and Conceptual Design, Version 1.0,” TransCelebrate Biopharma, Inc., Nov. 7, 2019, 4 pp.
“Digital Data Flow Solution Framework and Conceptual Design, Version 1.0,” TransCelebrate DDF Project Team, TransCelebrate Biopharma, Inc., Nov. 1, 2019, 46 pp.
“Reusable Asset Specification, Version 2.2,” Object Management Group (OMG), accessed from https://www.omg.org/spec/RAS/2.2/PDF, Nov. 2005, 121 pp.
Nelson et al., PowerPoint presented at 2019 Clinical Data Interchange Standards Consortium (CDISC) US Interchange, San Diego, California, Oct. 14-18, 2018, 19 pp.
“Cost of Developing a New Drug,” Tufts Center for the Study of Drug Development (CSDD), Tufts University, School of Medicine, Nov. 18, 2014, 30 pp.
“Drug Approval Process—Infographic,” U.S. Food and Drug Administration (FDA), accessed from http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/UCM284393.pdf, accessed on Jan. 20, 2015, 2 pp.
Burrows, “Report: The 8 biggest challenges facing clinical trail professionals,” Informa Connect, Clinical & Medical Affairs, accessed from https://informaconnect.com/report-biggest-challenges-clinical-trials-pt-1/, Nov. 30, 2016, 4 pp.
Nelson et al., “3D Standardized in Clinical Development to achieve End-to-End Automation,” Intilaris, Nurocor, 2019 Clinical Data Interchange Standards Consortium (CDISC), Oct. 14-18, 2019, 5 pp.
“How to avoid costly clinical research delays,” MESM Blog, accessed from https://www.mesm.com/blog/tips-to-help-you-avoid-costly-clinical-research-delays/, dated Jan. 16, 2020, accessed on Mar. 4, 2021, 4 pp.
Hargreaves, “Clinical trails and their patients: The rising costs and how to stem the loss,” Pharmafile, accessed from http://www.pharmafile.com/news/511225/clinical-trials-and-their-patients-rising-costs-and-how-stem-loss, Mar. 11, 2016, 8 pp.
Woodcock et al., “Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both,” Massachusetts Medical Society, The New England Journal of Medicine, Jul. 6, 2017, 9 pp.
“Nurocor products allow customers to automate clinical development processes from protocol to submission,” NUROCOR Brochure, accessed from www.nurocor.com, accessed on Sep. 10, 2019, 4 pp.
“Streamline Your Clinical Operations Through Smarter Standardization,” Nurocor, PowerPoint presented at 2019 Clinical Data Interchange Standards Consortium (CDISC), US Interchange, San Diego, California, Oct. 18, 2019, 22 pp.
“Facts about Clinical Trials,” Arena International, accessed from https://web.archive.org/web/20180914235739/http://www.arena-international.com/clinicaltrials/facts-about-clinical-trials/1063.article, dated Sep. 14, 2018, accessed on Mar. 4, 2021, 1 pp.
“Study Data Tabulation Model Implementation Guide: Human Clinical Trials,” Prepared by the CDISC Submission Standards Team, cdisc, Version 3.3 (Final), Clinical Data Interchange Standards Consortium, Inc., Nov. 20, 2018, 426 pp.
“Biotech Out-Licensed Optimized Compound Value—Product Oriented Licensing Strategy,” Intilaris LifeSciences, accessed on Sep. 9, 2020, 6 pp.
Ganic et al., “PhUSE EU Connect 2018—Structure and Standardized Study Definition drives early study setup for added business benefits,” Bayer, Intilaris, Nov. 2018, 20 pp.
Getz et al., “Measuring the Incidence, Causes, and Repercussions of Protocol Amendments,” Therapeutic Innovation and Regulatory Science, Drug Information Journal, vol. 45, Issue 3, May 2011, pp. 265-275.
Seguine, “Overcoming the Industry's Data Crisis,” Clinical Link, EPC, Aug. 2019, pp. 38-41.
“The Case for CDISC Standards,” CDISC, Business Case for CDISC Standards, Stage V, Sep. 30, 2014, 45 pp.
“Information technology—Metadata registries (MDR)—Part 1: Framework,” International Standards, ISO/IEC 11179-1, Second Edition, Sep. 15, 2004, 32 pp.
“Information technology—Metadata registries (MDR)—Part 2: Classification,” International Standards, ISO/IEC 11179-2, Second Edition, Nov. 15, 2005, 16 pp.
“Information technology—Metadata registries (MDR)—Part 3: Registry metamodel and basic attributes,” International Standards, ISO/IEC 11179-3, Third Edition, Feb. 15, 2013, 244 pp.
“Information technology—Metadata registries (MDR)—Part 4: Formulation of data definitions,” International Standards, ISO/IEC 11179-4, Second Edition, Jul. 15, 2004, 16 pp.
“Information technology—Metadata registries (MDR)—Part 5: Naming principles,” International Standards, ISO/IEC 11179-5, Third Edition, Apr. 1, 2015, 32 pp.
“Information technology—Metadata registries (MDR)—Part 6: Registration,” International Standards, ISO/IEC 11179-6, Third Edition, Aug. 1, 2015, 72 pp.
Advisory Action from U.S. Appl. No. 17/305,366 dated Jan. 3, 2025, 2 pp.
Response to Final Office Action dated Sep. 18, 2024 from U.S. Appl. No. 17/305,368 filed Dec. 17, 2024, 17 pp.
Response to Final Office Action dated Sep. 28, 2024 from U.S. Appl. No. 17/305,366 filed Nov. 27, 2024, 18 pp.
Jiang et al., “Using Semantic Web technologies for the generation of domain-specific templates to support clinical study metadata standards”, Journal of Biomedical Semantics, vol. 7, No. 10, BioMed Central, Mar. 6, 2016, 10 pp., https://doi.org/10.1186/s13326-016-0053-5.
Office Action from U.S. Appl. No. 17/305,366 dated Jan. 29, 2024, 32 pp.
Response to Office Action dated Jan. 29, 2024 from U.S. Appl. No. 17/305,366 filed May 29, 2024, 21 pp.
Response to Office Action dated Mar. 8, 2024 from U.S. Appl. No. 17/305,368 filed Jul. 8, 2024, 18 pp.
Office Action from U.S. Appl. No. 17/305,366 dated Mar. 24, 2025, 28 pp.
Final Office Action from U.S. Appl. No. 17/305,368 dated Apr. 22, 2025, 16 pp.
Response to Office Action dated Jan. 6, 2025 from U.S. Appl. No. 17/305,368 filed Apr. 7, 2025, 16 pp.